Psychopharmacology – A Masters Class 2021 (CME VIDEOS)

Learning Objectives

Upon completion of this activity, participants will be better able to apply:

•  Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment
•  Study the interface between neurology and psychiatry
•  Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode
•  Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress and anxiety disorder
•  Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period
•  Review the appropriate use of medications in the treatment of sleep disorders
•  Access psychopharmacologic treatment of eating disorders
•  Summarize the interface between medicine and psychiatric disorders with an emphasis on cardiovascular disease and cancer
•  Review the appropriate use of stimulants in the treatment of attention and ADHD disorders as well as their use as an adjunct to antidepressant treatment
•  Identify psychopharmacologic treatment for the borderline personality disorder
•  Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis
•  Recognize when to utilize ECT and TMS for the treatment of depression
•  Discuss standard psychopharmacologic treatments that have now been proven to be ineffective
•  Give examples of the latest advances and problems associated with treatment approaches in the child, adolescent and geriatric populations

TOPICS / SPEAKERS: